v3 Template
D

Dash Bio

Biotechnology / Bioanalysis ~30 employees
Founded
--
Employees (Est.)
~30
3 leaders known
Total Funding
$17.5M
Funding Rounds
2
Last Funding
2025-07-23

About Dash Bio

Dash Bio is a bioanalysis CRO (Contract Research Organization) focused on delivering radically faster turnaround times, transparent pricing, and guaranteed results. They aim to reinvent the capabilities of a CRO with a modern approach to bioanalysis, emphasizing speed, scalability, and quality.

Products & Services

Method Development:Custom-design and development of bioanalytical assays for any project with rapid method transfers and fixed pricing.
Method Validation:Fixed price automated assay validation with locked protocols, full audit trails, and guaranteed consistency.
ELISA/MSD:High-throughput ELISA and MSD assays with flexible formats and readouts for scalable, consistent ligand-binding analysis.
LC-MS:Fast, high-throughput LC-MS workflows using advanced chromatography and automated prep for precise compound quantitation.
qPCR:Ultra-high-throughput qPCR on automated platforms, scaling nucleic acid analysis from research to clinical studies.

Specialties

Bioanalytical Assays Method Development and Validation ELISA/MSD LC-MS qPCR High-Throughput Analysis Automated Platforms

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Venture Capital
T: -
FT: Venture Capital 		A: 11000000
MR: -
FA: 11 million
FAN: 11000000 		D: 2025-07-23
FD: 2025-07-23 		6 investors
2 RT: Seed
T: -
FT: Seed 		A: 6500000
MR: -
FA: $6.5M
FAN: 6500000 		D: 2024-10-24
FD: 2024-10-24 		4 investors
Venture Capital Latest
2025-07-23
$11.0M
6 investors (Pro only)
Seed 2024-10-24
$6.5M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

Dave Johnson

Chief Executive Officer

LinkedIn (Pro only)
A

Ander Tallett

Chief Operating Officer

LinkedIn (Pro only)
E

Ely Porter

Chief Scientific Officer

LinkedIn (Pro only)

Recent News

Dash Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
dash.bio
Industries
Biotechnology / Bioanalysis
Company Size
~30 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro